Max Spielberg

President at Genexa | Atlanta, Georgia, United States

About Max Spielberg

Max Spielberg serves as the President of Genexa, a pioneering pharmaceutical company committed to revolutionizing the over-the-counter (OTC) medicine landscape. With a robust background in health law and a passion for entrepreneurship, Max has been instrumental in steering Genexa towards its mission of creating healthier alternatives to conventional OTC products. Under his leadership, the company has successfully developed the world’s only certified organic and non-GMO medicines, effectively removing harmful synthetics that are prevalent in traditional pharmaceuticals. This innovative approach not only aligns with Max's vision of making the world a better place but also positions Genexa as a leader in the organic health movement.

Max's expertise in legal research, litigation, and mergers & acquisitions has been crucial in navigating the complex regulatory landscape of the healthcare industry. His strategic insights have facilitated key partnerships and collaborations that enhance Genexa's market presence and expand its product offerings. As a certified B-Corp, Genexa embodies a commitment to social responsibility, and Max's leadership ensures that the company remains dedicated to improving public health while maintaining high ethical standards.

In addition to overseeing daily operations, Max is actively involved in key projects that focus on innovation in health technology, aiming to further enhance the efficacy and safety of OTC medicines. His dedication to advancing healthcare solutions is evident in every aspect of Genexa's operations, making him a vital force in the movement towards a healthier future for consumers everywhere.

Max Spielberg Work